We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Octagon5.333% | LSE:48DB | London | Bond |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
RNS Number:6628B Octagon Healthcare Funding PLC 07 August 2007 Octagon Healthcare Funding PLC Directors' report and financial statements 31 December 2006 Registered number: 4870001 Contents Company information 1 Directors' report 2 Statement of directors' responsibilities 4 Independent auditors' report to the members of Octagon Healthcare Funding PLC 5 Profit and loss account 7 Balance sheet 8 Notes 9 Company information Directors M Baybutt (Alt for IJ Wells) A Bell WR Doughty (Alt for BS Williams) WW McNaught JM Sisson (Chairman) JW Ward IJ Wells BS Williams Secretary DC Howe Registered office The Norfolk & Norwich University Hospital Colney Lane Norwich NR4 7UY Auditors KPMG Audit Plc 8 Salisbury Square London EC4Y 8BB United Kingdom Directors' report The directors present their report and the audited financial statements for the year ended 31 December 2006. Principal activity The principal activity of the Company is the raising of finance through the bond market and its onward loan to a related party, Octagon Healthcare Limited, during the refinancing of that company's operations in December 2003. Business review In December 2003 Octagon Healthcare Limited, a related company involved in the finance, construction and part operation of the Norfolk and Norwich University Hospital under the Government's Private Finance Initiative, refinanced its operations and negotiated an extension of the initial contract term with the Norfolk and Norwich University Hospital NHS Trust (The Trust) to 35 years. Octagon Healthcare Funding PLC raised funds for that refinancing through the bond market (the Bond) and on loaned them to Octagon Healthcare Limited. Key performance indicators (KPIs) 1. Performance deductions under the service contract The Company is required to pay interest and repay a proportion of the capital raised by the Bond on specified dates during the year. The ability to meet these requirements is dependant upon the performance of a related company, Octagon Healthcare Limited. Financial penalties are levied against Octagon Healthcare Limited by The Trust in the event of performance standards not being achieved or parts of the hospital becoming unavailable for their anticipated use in accordance with the detailed criteria set out in the Project Documents. Where appropriate deductions are passed on to the service provider but the quantum is an indication of that company's performance. For the year ending 31 December 2006 no deductions had been levied against the Octagon Healthcare Limited (2005: #Nil) and therefore the Company met all obligations to make the required payments under terms of the Bond. 2. Financial performance The Company has modelled the anticipated financial outcome of the project across the term of the agreement up to the date of the first break option; this option is exercisable by The Trust in 2037. The Company monitors actual financial performance against this anticipated performance. As at 31 December 2006, the Company's performance against this measure was satisfactory. Position of the Company at the year end The Company is continuing to provide finance to Octagon Healthcare Limited which in turn is continuing to provide a satisfactory facilities management service at the Norfolk and Norwich University Hospital. Principal risks and uncertainties The Norfolk and Norwich University Hospital NHS Trust (The Trust) is the sole client of Octagon Healthcare but the directors consider that no risk arises from such a small client base since the Secretary for Health has underwritten The Trust's obligations. Performance risk under the Project Agreement and related contracts entered into by Octagon Healthcare Limited is passed on to the service provider. The obligations of its subcontractor are underwritten by a parent company guarantee. Financial risk management policies and objectives The Company's principal financial instruments comprises of a fixed rate bond details of which are given in Note 13. Dividends The directors do not recommend the payment of a dividend (2005: #Nil). Directors The directors who held office during the year were as follows: M Baybutt (Alt for IJ Wells) Appointed 12 September 2006 A Bell Appointed 21 February 2007 ME Black Resigned 21 February 2007 WR Doughty Alt for BS Williams RW Jewson Resigned 1 August 2006 WW McNaught GA Neville Resigned 12 September 2006 JM Sisson Appointed 1 August 2006 JW Ward IJ Wells Appointed 12 September 2006 BS Williams None of the directors who held office at the end of the financial year had any disclosable interest in the shares of the group companies. Financial instruments The financial risk management objectives and policies of the Company, together with an analysis of the exposure to such risks, as required under the Companies Act are set out in Note 13 of the Notes on the financial statements. Disclosure of information to auditors The directors who held office at the date of approval of this directors' report confirm that, so far as they are each aware, there is no relevant audit information of which the Company's auditors are unaware; and each director has taken all the steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the Company's auditors are aware of that information. Policy on payment of creditors It is policy to comply with the payment terms agreed with suppliers. Where payment terms are not negotiated the Company endeavours to adhere with suppliers standard terms. Auditors During the year KPMG Audit Plc were re-appointed as auditors of the company. In accordance with Section 385 of the Companies Act 1985, a resolution to reappoint KPMG Audit Plc as auditors is to be proposed at the next Annual General meeting. By order of the board DC Howe The Norfolk & Norwich University Hospital Secretary Colney Lane Date:4 July 2007 Norwich NR4 7UY Statement of directors' responsibilities in respect of the directors' report and the financial statements The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations. Company law requires the directors to prepare financial statements for each financial year. Under that law they have elected to prepare the financial statements in accordance with UK Accounting Standards and applicable law (UK Generally Accepted Accounting Practice). The financial statements are required by law to give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: * select suitable accounting policies and then apply them consistently; * make judgments and estimates that are reasonable and prudent; * state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and * prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that its financial statements comply with the Companies Act 1985. They have general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the company and to prevent and detect fraud and other irregularities. Independent auditors' report to the members of Octagon Healthcare Funding PLC We have audited the financial statements of Octagon Healthcare Funding Plc for the year ended 31 December 2006 which comprise the Profit and Loss Account, the Balance Sheet, and the related notes. These financial statements have been prepared under the accounting policies set out therein. This report is made solely to the company's members, as a body, in accordance with section 235 of the Companies Act 1985. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. Respective responsibilities of directors and auditors The directors' responsibilities for preparing the financial statements in accordance with applicable law and UK Accounting Standards (UK Generally Accepted Accounting Practice) are set out in the Statement of Directors' Responsibilities on page 4. Our responsibility is to audit the financial statements in accordance with relevant legal and regulatory requirements and International Standards on Auditing (UK and Ireland). We report to you our opinion as to whether the financial statements give a true and fair view and are properly prepared in accordance with the Companies Act 1985. We also report to you whether in our opinion the information given in the Directors' Report is consistent with the financial statements. In addition we report to you if, in our opinion, the company has not kept proper accounting records, if we have not received all the information and explanations we require for our audit, or if information specified by law regarding directors' remuneration and other transactions is not disclosed. We read the Directors' Report and consider the implications for our report if we become aware of any apparent misstatements within it. Basis of audit opinion We conducted our audit in accordance with International Standards on Auditing (UK and Ireland) issued by the Auditing Practices Board. An audit includes examination, on a test basis, of evidence relevant to the amounts and disclosures in the financial statements. It also includes an assessment of the significant estimates and judgments made by the directors in the preparation of the financial statements, and of whether the accounting policies are appropriate to the company's circumstances, consistently applied and adequately disclosed. We planned and performed our audit so as to obtain all the information and explanations which we considered necessary in order to provide us with sufficient evidence to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or other irregularity or error. In forming our opinion we also evaluated the overall adequacy of the presentation of information in the financial statements. Independent auditors' report to the members of Octagon Healthcare Funding PLC (continued) Opinion In our opinion: * the financial statements give a true and fair view, in accordance with UK Generally Accepted Accounting Practice, of the state of the company's affairs as at 31 December 2006 and of its profit for the year then ended; * the financial statements have been properly prepared in accordance with the Companies Act 1985; and * the information given in the Directors' Report is consistent with the financial statements. KPMG Audit Plc (Date) Chartered Accountants Profit and loss account for the year ended 31 December 2005 Note 2006 2005 # # Turnover - - Net operating costs 2 (13,154) (49) Operating loss (13,154) (49) Interest payable and similar charges 3 (16,219,746) (16,287,488) Other interest receivable and similar income 4 16,251,190 16,318,513 Profit on ordinary activity before taxation 18,290 30,976 Taxation on profit on ordinary activity 5 (3,475) (2,494) Profit for the financial year 14,815 28,482 There were no other recognised gains and losses for the year other than the profit stated above. There is no difference between the historical cost profit and the profit stated above. All of the results relate to continuing activities. Movements on reserves are shown in note 11. The notes on pages 9 to 14 form part of these financial statements. Balance sheet at 31 December 2006 Note 2006 2005 # # Current asset Debtors (#299,769,518 (2005: #302,419,255) due after more than one year) 6 302,513,882 313,455,912 Cash at bank and in hand 81,282 31,690 302,595,164 313,487,602 Creditors: amounts falling due 8 (2,710,765) (10,968,281) within one year Net current assets 299,884,399 302,519,321 Creditors: amounts falling due 9 (299,769,518) (302,419,255) after more than one year Net assets 114,881 100,066 Capital and reserves Called up share capital 10 50,000 50,000 Profit and loss account 11 64,881 50,066 Equity shareholders' funds 12 114,881 100,066 These financial statements were approved by the board of directors on 20 March 2007 and were signed on its behalf by: WR Doughty Director The notes on pages 9 to 14 form part of these financial statements. Notes (forming part of the financial statements) 1 Accounting policies (i) Basis of preparation of the accounts The financial statements have been prepared in accordance with applicable accounting standards and under historical accounting rules. Under Financial Reporting Standard 1 the Company is exempt from the requirement to prepare a cash flow statement on the grounds of that a parent undertaking includes the company in its own published consolidated financial statements. As the company is a subsidiary of Octagon Healthcare Group Limited, the company has taken advantage of the exemption contained in FRS 8 and has therefore not disclosed transactions or balances with entities which form part of the group (or investees of the group qualifying as related parties). The consolidated financial statements of Octagon Healthcare Group Limited, within which this company is included, can be obtained from the address given in note 14. (ii) Taxation Deferred taxation is recognised without discounting, in respect of all timing differences between the treatment of certain items for taxation and accounting purposes which have arisen but not reversed by the balance sheet date, except as otherwise required by FRS 19. 2 Net operating cost 2006 2005 # # Other charges, net of recovery 13,154 49 3 Interest payable and similar charges 2006 2005 # # Interest on bonds 16,219,746 16,287,307 Other interest payable - 181 _______ _______ 16,219,746 16,287,488 Notes (continued) 4 Other interest receivable and similar income 2006 2005 # # Interest receivable on inter group loans 16,250,160 16,317,844 Interest receivable on bank deposits 1,030 669 16,251,190 16,318,513 5 Taxation Analysis of charge in year 2006 2005 # # UK corporation tax Current tax on income for the year @ 19% (2005:19%) 3,475 5,885 Adjustments in respect of prior - (3,391) periods Tax on profit on ordinary 3,475 2,494 activities Factors affecting the tax charge for the current year The current tax charge for the year is the same (2005: lower) as the standard rate of corporation tax in the UK 19% (2005: 19%). The differences are explained below. 2006 2005 # # Current tax reconciliation Profit on ordinary activities before tax 18,290 30,976 Current tax at 19% (2005: 19%) 3,475 5,885 Effects of: Adjustments in respect of prior periods - (3,391) Total current tax charge (see above) 3,475 2,494 It has been announced that the corporation tax rate applicable to the Company is expected to change from 30% to 28% from 1 April 2008. Notes (continued) 6 Debtors 2006 2005 # # Inter group loan (note 7) 302,419,255 305,197,650 Amounts receivable from other group members 50,000 65,302 Prepayments and accrued income 44,627 8,192,960 _______ _______ 302,513,882 313,455,912 7 Debtors: amounts falling due after more than one year 2006 2005 # # Inter group loan: Instalments due within 1 year 2,649,737 2,778,395 1-2 years 1,939,056 2,649,737 2-5 years 10,896,087 6,317,491 Over 5 years 286,934,375 293,452,027 302,419,255 305,197,650 Less: Amount due within 1 year 2,649,738 2,778,395 299,769,517 302,419,255 The inter group loan is repayable in half yearly instalments and is subject to a fixed rate of interest of 5.343% calculated on a half yearly basis. 8 Creditors: amounts falling due within one year 2006 2005 # # Bond proceeds (note 9) 2,649,737 2,778,395 Corporation tax 3,361 5,885 Accruals and deferred income 44,544 8,184,001 Inter group balances 13,123 - 2,710,765 10,968,281 Notes (continued) 9 Creditors: amounts falling due after more than one year 2006 2005 # # Bond proceeds Instalments due within 1 year 2,649,737 2,778,395 1-2 years 1,939,056 2,649,737 2-5 years 10,896,087 6,317,491 Over 5 years 286,934,375 293,452,027 302,419,255 305,197,650 Less: Amount due within 1 year 2,649,737 2,778,395 299,769,518 302,419,255 The bonds are secured by a fixed and floating charge over the assets of the Company. The bond is repayable in half-yearly instalments and is subject to an interest rate of 5.333% calculated on a half yearly basis. 10 Called up share capital 2006 2005 Equity # # Authorised 50,000 shares of #1 each 50,000 50,000 Called up and fully paid 50,000 shares of #1 each 50,000 50,000 11 Reserves Profit and loss account 2005 # At beginning of the year 50,066 Retained profit for the year 14,815 At end of the year 64,881 12 Reconciliation of movements in equity shareholders' funds 2006 2005 # # Profit for the year 14,815 28,482 Opening equity shareholders' funds 100,066 71,584 Closing equity shareholders' funds 114,881 100,066 Notes (continued) 13 Financial instruments Exposure to credit and interest rate risks arise in the normal course of the Company's business. Credit policy Although The Norfolk and Norwich University Hospital NHS Trust (The Trust) is the only client of the Octagon Healthcare Group the directors are satisfied that The Trust will be able to fulfil its collateral obligations under the PFI contract that are in turn underwritten by the Secretary of State for Health. Effective interest rates and repricing analysis In respect of income-earning financial assets and interest-bearing financial liabilities, the following table indicates their effective interest rates at the balance sheet date and the period in which they reprice: 2006 Effective Total One 1 - 2 2 - 5 5 years year or years years or more Interest rate less #'000 #'000 #'000 #',000 #'000 Cash 2% 81 81 - - - Inter group loans 5.343% 302,419 2,649 1,939 10,896 286,934 Bonds 5.333% (302,419) (2,649) (1,939) (10,896) (286,934) ______ ______ ______ ______ ______ 81 81 - - - ---- ---- ---- ---- ---- 2005 Effective Total One 1 - 2 2 - 5 5 years Interest Year or years years or more rate less #'000 #'000 #'000 #'000 #'000 Cash 2% 32 32 - - - Inter group loans 5.343% 305,198 2,778 2,650 6,318 293,452 Bonds 5.333% (305,198) (2,778) (2,650) (6,318) (293,452) ______ ______ ______ ______ ______ 32 32 - - - ---- ---- ---- ---- ---- Notes (continued) 13 Financial instruments (continued) Fair values The fair values together with the carrying amounts shown in the balance sheet of all financial assets and financial liabilities are as follows: 2006 2006 2005 2005 Carrying Fair value Carrying Fair value amount Amount # # # # Cash 81,282 81,282 31,690 31,690 Inter group loans 302,419,255 299,688,334 305,197,650 317,339,832 Bonds (302,419,255) (314,044,251) (305,197,650) (338,555,753) 81,282 (14,274,635) 31,690 (21,184,231) Estimation of fair values The following summarises the major methods and assumptions used in estimating the fair values of financial instruments reflected in the table. * Fair value of the bonds is the quoted price of the bonds. * Fair value of the inter-group loans is calculated based upon discounted expected future principal and interest cash flows. Where fair values have been assessed by discounting carrying amounts of future principal and interest cash values, the discount rates used are 5.0625% (2005: 5.0625%) pa. Sensitivity analysis Since the Company has offsetting fixed rate financial assets and liabilities, a general increase of one percentage point in interest rates would not significantly impact the profits of the Company. 14 Utimate parent company and parent undertaking of larger group of which the company is a member The Company is a subsidiary undertaking of Octagon Healthcare Group Limited incorporated in the United Kingdom. The largest and smallest group in which the results of the Company are consolidated is that headed by Octagon Healthcare Group Limited. The consolidated account of the group is available to the public and may be obtained from The Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY. 15 Profit on ordinary activities before taxation Auditors' remuneration of the Company is borne by a related party. The directors of the company did not receive any emoluments from the company during the year (2005: #Nil). Apart from the directors there were no other employees of the company during the year (2005: Nil). This information is provided by RNS The company news service from the London Stock Exchange END FR UBRURBBRWRAR
1 Year Octagon5.333% Chart |
1 Month Octagon5.333% Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions